Results 111 to 120 of about 546,162 (334)
Cannabidiol (CBD) has numerous therapeutic properties, and is used to treat neurological conditions, such as neuroinflammation. However, the optimal dose of CBD to penetrate the brain requires further investigation. The primary aim of this study was to use a mouse model and the intrabuccal route for CBD administration to determine the optimal dose at ...
Oluwadara Pelumi Omotayo+4 more
wiley +1 more source
A case of urinary tract infection caused by Raoultella planticola after a urodynamic study
Here we report the case of a patient who developed urinary tract infection after a urodynamic study. The causative agent was Raoultella planticola, a rare opportunistic pathogen that usually invades immunocompromised patients.
Murat Tuğcu+4 more
doaj
Discussion on Bacterial Infections of the Urinary Tract [PDF]
Leonard S. Dudgeon
openalex +1 more source
Kidney stones cause significant pain and healthcare costs. Current prediction, diagnosis, and treatment options are limited. Extracellular vesicles (EVs), rich in proteins, lipids, and nucleic acids, offer a promising solution. This review explores the roles of EVs in kidney stone management, highlighting their potential as biomarkers and therapeutic ...
Wang Zhu+3 more
wiley +1 more source
Coliform Bacillus Infections of the Male Urinary Tract [PDF]
A. F. Rook
openalex +1 more source
Thrombocytopenia and Anemia After Cardiac Surgery
American Journal of Hematology, EarlyView.
Myriam Beshai+2 more
wiley +1 more source
This study characterizes a multidrug‐resistant and strong biofilm‐forming Enterococcus faecalis strain obtained from a shrimp sample in Bangladesh. ABSTRACT Enterococcus faecalis is known for its ability to form strong biofilms and its role as an opportunistic pathogen. In this study, we screened and characterized a multidrug‐resistant (MDR) and strong
Md. Ashek Ullah+4 more
wiley +1 more source
The Chemotherapy of Non-Tuberculous Infections of the Urinary Tract [PDF]
F R Kilpatrick, K.S. Maclean
openalex +1 more source
Objective An unmet need exists for glucocorticoid‐sparing treatments for patients with polymyalgia rheumatica (PMR). The antibody‐drug conjugate ABBV‐154 comprises adalimumab conjugated to a glucocorticoid receptor modulator. We evaluated ABBV‐154 versus placebo in patients with glucocorticoid‐dependent PMR.
Robert F. Spiera+14 more
wiley +1 more source
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
A. Flores-Mireles+3 more
semanticscholar +1 more source